Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
144.00    -1.00 (-0.69%)
Bid:
137.00
Ask:
144.00
Spread: 7.00 (5.109%)
Market Cap: £113.00m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Trading Statement

14 Jan 2021 07:00

RNS Number : 6127L
Xaar PLC
14 January 2021
 

Xaar plc

 

Trading update 

 

Xaar plc ("Xaar", "the Group" or "the Company"), the leading inkjet printing technology, today announces a trading update for the year ended 31 December 2020.

 

TRADING

 

The Board is pleased to announce that, with the on-going successful implementation of the new strategy, trading was in line with its expectations. Revenue for the year was approximately £48m and in line with that recorded in FY2019.

 

The Printhead business continues to perform well with continued success in winning new customers. The customer-centric approach and focus on markets in which we have a competitive advantage is driving new business wins and seeing customers continue to re-engage. Additionally, our ImagineX platform is being successfully rolled out with a targeted product roadmap and clear growth opportunities ahead.

 

Despite the impact by COVID-19, our Product Print Systems business (EPS) has made progress with the strategy of developing a modular approach to products and, following the successful implementation of operational changes, the business is well placed for the future.

 

We have made further progress with product development and testing in Xaar 3D, despite continued COVID-19 related delays, and we continue to work closely with Stratasys to optimise the approach to commercialisation of the product range. 

 

BALANCE SHEET AND LIQUIDITY

 

The Group retains a strong balance sheet and cash position. Cash and cash equivalents at 31 December 2020 were £20.2m. This was driven by positive operational cash generation in both Printhead and EPS, as well as maintaining a strong focus on cash and disciplined cost controls.

 

CURRENT TRADING AND OUTLOOK

 

Despite the most recent COVID-19 lockdown, with pro-active management, we have maintained operational performance. Whilst COVID-19 continues to represent a key risk the order book remains strong with a positive pipeline. We continue to rigorously review opportunities available in the market, remaining focused on our strategy, and are on-track to return to profitability and growth.

 

 

John Mills, Chief Executive Officer, commented:

 

"We are very pleased with performance for the year which is a testament to the efforts of the team in extraordinary circumstances. We are one year into delivering our strategy and it is clearly having a positive impact, notably as existing customers continue to engage, and we are winning new business. We remain excited by the future and will remain disciplined in delivering long-term sustainable growth."

 

Enquiries:

 

Xaar plc

 

Ian Tichias, Chief Finance Officer

& Company Secretary

+44 (0) 1223 423 663 

John Mills, Chief Executive Officer

 

 

 

Tulchan Communications

James Macey White

Giles Kernick

Tom Blundell

 

 

 

+44 (0) 207 353 4200

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDXLFFFFLFBBV
Date   Source Headline
2nd Jan 20182:52 pmRNSTotal Voting Rights
14th Dec 201711:11 amRNSAgreement
1st Dec 20171:55 pmRNSTotal Voting Rights
21st Nov 20178:56 amRNSNOTIFICATION OF MAJOR HOLDINGS
20th Nov 20177:00 amRNSTrading Statement
15th Nov 20179:20 amRNSXaar strengthens 2020 vision with two developments
1st Nov 201710:04 amRNSTotal Voting Rights
2nd Oct 20172:37 pmRNSTotal Voting Rights
8th Sep 201711:34 amRNSDirector/PDMR Shareholding
6th Sep 20172:43 pmRNS2017 Interim Results
6th Sep 20177:00 amRNS2017 Interim Results
1st Sep 201712:21 pmRNSTotal Voting Rights
17th Aug 201711:55 amRNSNOTIFICATION OF MAJOR HOLDINGS
9th Aug 20177:00 amRNSDirector change
1st Aug 20172:26 pmRNSTotal Voting Rights
12th Jul 20177:00 amRNSTrading Statement
4th Jul 20177:00 amRNSNotice of Scheduled Trading Statement
3rd Jul 20177:00 amRNSTotal Voting Rights
30th Jun 20179:36 amRNSBlock listing Interim Review
1st Jun 201711:33 amRNSTotal Voting Rights
18th May 201711:10 amRNSREPLACEMENT: Grant of Options
18th May 20178:56 amRNSGrant of Options
16th May 20171:24 pmRNSResult of AGM
2nd May 20171:13 pmRNSTotal Voting Rights
2nd May 20177:00 amRNSBoard Appointment
26th Apr 201710:05 amRNSNotice of 2017 AGM
18th Apr 20177:00 amRNSDirector/PDMR Shareholding - SIP Purchase
11th Apr 20179:35 amRNSDirector/PDMR Shareholding
11th Apr 20179:19 amRNSDirector/PDMR Shareholding
6th Apr 20174:19 pmRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
5th Apr 201712:34 pmRNSTotal Voting Rights - Replacement
3rd Apr 20172:08 pmRNSTotal Voting Rights
3rd Apr 20179:43 amRNSWORLD LEADING 3D CENTRE FORMALLY OPENED
29th Mar 20171:11 pmRNSConfirmation of Board Changes
28th Mar 20173:22 pmRNSDirector/PDMR Shareholding
24th Mar 20172:42 pmRNSNotification of Major Interest in Shares
22nd Mar 20177:00 amRNSFinal Results
8th Mar 20173:11 pmRNSNotice of Scheduled Results
1st Mar 20174:38 pmRNSTotal Voting Rights
1st Feb 20175:42 pmRNSTotal Voting Rights
24th Jan 20177:00 amRNSAppointment of Chief Financial Officer
11th Jan 20177:00 amRNSXerox partnership agreement
3rd Jan 20174:23 pmRNSBlock listing Six Monthly Return
3rd Jan 20174:20 pmRNSTotal Voting Rights
15th Dec 20167:00 amRNSScheduled Trading Statement
15th Dec 20167:00 amRNSInvestment in 3D Printing
12th Dec 20167:00 amRNSNotice of Scheduled Trading Statement
1st Dec 20161:52 pmRNSTotal Voting Rights
1st Nov 20163:48 pmRNSTotal Voting Rights
21st Oct 20167:00 amRNSBoard change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.